8-K

Company

Tvardi Therapeutics, Inc.

Filed

June 5, 2019

Period of Report

June 4, 2019

Accession Number

0001193125-19-166293

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →